BRPI0819854A2 - Enumeração e caracterização automatizada de células de melanoma circulantes no sangue - Google Patents

Enumeração e caracterização automatizada de células de melanoma circulantes no sangue

Info

Publication number
BRPI0819854A2
BRPI0819854A2 BRPI0819854-3A BRPI0819854A BRPI0819854A2 BR PI0819854 A2 BRPI0819854 A2 BR PI0819854A2 BR PI0819854 A BRPI0819854 A BR PI0819854A BR PI0819854 A2 BRPI0819854 A2 BR PI0819854A2
Authority
BR
Brazil
Prior art keywords
characterization
melanoma cells
blood circulating
circulating melanoma
automated enumeration
Prior art date
Application number
BRPI0819854-3A
Other languages
English (en)
Inventor
Mark Carle Connelly
Galla Chandra Rao
Leon Wmm Terstappen
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of BRPI0819854A2 publication Critical patent/BRPI0819854A2/pt
Publication of BRPI0819854B1 publication Critical patent/BRPI0819854B1/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70589—CD45
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0819854-3A 2007-11-27 2008-10-20 Método para isolar, enriquecer e analisar células de melanoma circulantes em uma amostra de sangue BRPI0819854B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US434507P 2007-11-27 2007-11-27
US61/004,345 2007-11-27
PCT/US2008/080436 WO2009070392A1 (en) 2007-11-27 2008-10-20 Automated enumeration and characterization of circulating melanoma cells in blood

Publications (2)

Publication Number Publication Date
BRPI0819854A2 true BRPI0819854A2 (pt) 2015-06-16
BRPI0819854B1 BRPI0819854B1 (pt) 2019-06-04

Family

ID=40670042

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819854-3A BRPI0819854B1 (pt) 2007-11-27 2008-10-20 Método para isolar, enriquecer e analisar células de melanoma circulantes em uma amostra de sangue

Country Status (12)

Country Link
US (1) US20090136946A1 (pt)
EP (1) EP2225563B1 (pt)
JP (1) JP5479355B2 (pt)
KR (1) KR101604649B1 (pt)
CN (1) CN101878429B (pt)
BR (1) BRPI0819854B1 (pt)
CA (1) CA2706442C (pt)
DK (1) DK2225563T3 (pt)
HK (2) HK1148068A1 (pt)
IL (1) IL205864A (pt)
MX (1) MX2010005811A (pt)
WO (1) WO2009070392A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010068812A1 (en) 2008-12-10 2010-06-17 Abqmr, Inc. Nuclear magnetic resonance apparatus, methods and associated technology
WO2010151109A1 (en) * 2009-06-26 2010-12-29 Erasmus University Medical Center Rotterdam Identifying circulating tumor cells (ctcs) using cd146 in breast cancers patients
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
TWI539158B (zh) * 2010-06-08 2016-06-21 維里德克斯有限責任公司 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
US9618515B2 (en) * 2011-07-21 2017-04-11 Janssen Diagnostics, Llc Assay to capture and detect circulating multiple myeloma cells from blood
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
PL2972359T3 (pl) 2013-03-15 2021-03-08 Menarini Silicon Biosystems S.P.A. Wzbogacanie krążących komórek nowotworowych poprzez deplecję białych krwinek
CN103472227A (zh) * 2013-09-18 2013-12-25 上海卫恒医疗器械有限公司 一种循环肿瘤细胞检测试剂盒、配套仪器及应用
WO2016191532A1 (en) 2015-05-26 2016-12-01 Creatv Microtech Inc. Use of circulating tumor cell mitotic index in cancer stratification and diagnostics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
DE19736691A1 (de) * 1997-08-22 1999-02-25 Michael Prof Dr Med Giesing Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
EP1030675B1 (en) * 1997-11-14 2009-08-12 The General Hospital Corporation Treatment of hematologic disorders
KR100399475B1 (ko) * 1998-02-12 2003-09-29 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 순환 중인 암세포의 신속하고 효과적인 분리 방법 및 이를위한 제제
US20010018192A1 (en) * 1998-02-12 2001-08-30 Terstappen Leon W.M.M. Labeled cells for use as an internal functional control in rare cell detection assays
US7029652B2 (en) * 1998-09-16 2006-04-18 The Regents Of The University Of California Method of treating tumors
US6551843B1 (en) * 1999-01-29 2003-04-22 Immunivest Corporation Methods for enhancing binding interactions between members of specific binding pairs
US6222096B1 (en) * 1999-03-01 2001-04-24 Stine Biotechnology Promoter and construct for plant transformation
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
CA2378182C (en) * 1999-07-28 2014-09-23 Genentech, Inc. Compositions and methods for the treatment of tumors
CA2404431C (en) * 2000-03-27 2011-06-07 Thomas Jefferson University Guanylyl cyclase c in the detection of stomach and esophageal cancers
AU2002218450A1 (en) * 2000-10-13 2002-04-22 Norwood Immunology Ltd Diagnostic indicator of thymic function
US7223596B2 (en) * 2003-09-05 2007-05-29 Wisconsin Alumni Research Foundation Malignant endothelial cell line and uses thereof in models for angiogenesis
WO2006130737A1 (en) * 2005-06-02 2006-12-07 Immunivest Corporation A method for assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
US20070037173A1 (en) * 2005-08-12 2007-02-15 Allard Jeffrey W Circulating tumor cells (CTC's): early assessment of time to progression, survival and response to therapy in metastatic cancer patients

Also Published As

Publication number Publication date
IL205864A0 (en) 2010-11-30
DK2225563T3 (en) 2015-02-09
EP2225563B1 (en) 2015-01-21
HK1148068A1 (en) 2011-08-26
IL205864A (en) 2016-12-29
KR20100101109A (ko) 2010-09-16
EP2225563A4 (en) 2011-11-16
CA2706442C (en) 2017-07-11
KR101604649B1 (ko) 2016-03-18
US20090136946A1 (en) 2009-05-28
EP2225563A1 (en) 2010-09-08
MX2010005811A (es) 2010-06-09
CN101878429A (zh) 2010-11-03
JP2011505012A (ja) 2011-02-17
CA2706442A1 (en) 2009-06-04
BRPI0819854B1 (pt) 2019-06-04
WO2009070392A1 (en) 2009-06-04
JP5479355B2 (ja) 2014-04-23
HK1148348A1 (en) 2011-09-02
CN101878429B (zh) 2015-05-20

Similar Documents

Publication Publication Date Title
BRPI0819854A2 (pt) Enumeração e caracterização automatizada de células de melanoma circulantes no sangue
BRPI0921822A2 (pt) composição compreendendo polímero e enzima
BR112012004982A2 (pt) monitoramento e rastreamento atividade atlética
BRPI0818741A2 (pt) equipamento e método de avaliação da presença de microorganismos no sangue
ATE544309T1 (de) Abwicklung von zellenneuauswahlen und zustandsübergängen für hsdpa
BRPI0908906A2 (pt) compostos heterocíclicos e usos dos mesmos
BRPI0814894A2 (pt) Diferenciação de células-tronco embrionárias de ser humano.
IT1390860B1 (it) Friggitrice e procedimento di cottura
DK2562248T3 (da) Differentiering af humane embryonale stamceller
ATE546433T1 (de) Quinolinderivate und ihre verwendung als fungizide
DK2250161T3 (da) Forbindelser med CRTH2-antagonistaktivitet
BR112012003709A2 (pt) compostos heterocíclicos e usos dos mesmos
ATE541211T1 (de) Verfahren zur beurteilung von zellen und zellkulturen
GB0701253D0 (en) Nucleic acid amplification and testing
ATE548355T1 (de) 4- (4-cyano-2-thioaryl) -dihydropyrimidinone und ihre verwendung
DE112007000789A5 (de) Verwendung von Bora-tetraazepentalenen
DK2107373T3 (da) Analysechip og analysefremgangsmåde
BRPI0814330A2 (pt) métodos e kits cirúrgicos
EP2008102A4 (en) DETECTION OF PROTEINS IN NEOPLASTIC CELLS IN CIRCULATION
BRPI0921862A2 (pt) inibidores de raf e seus usos
BRPI0817199A2 (pt) Identificaçãob e isolamento de células fetais e ácido nucleico
BRPI0814310A2 (pt) Enzima lecitina-colesterol acetiltransferase modificada
DK2325662T3 (da) Multi-indlæsnings- og multi-udlæsningsanalysator
FI20090161A0 (fi) Uusi solu ja siihen pohjautuvia terapeuttisia ja diagnostisia menetelmiä
EP2310559A4 (en) KRINGLE DOMAIN STRUCTURE SCAFFOLD SCAFFOLD LIBRARY AND USES THEREOF

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/06/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/06/2019, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2536 DE 13-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.